Products

Applied Strategies provides powerful off-the-shelf software and tailored solutions targeted to specific Life Sciences company needs.

Our Cennium™ software products are designed to help decision-makers make credible, value-creating decisions about drug development, drug portfolios, demand forecasting, and project budgeting. Our experienced industry professionals also provide the tailored training and product support to ensure that users gain the maximum advantages from our software products.

The Cennium suite of products includes:

Cennium ValueDriver™, Applied Strategies' flagship decision analytic-based asset valuation tool, evaluates alternative product development strategies and provides insight into the key drivers of program value and risk. The menu-driven interface guides the analyst through analysis set-up and input. Standard analyses are conducted with the touch of a button, and more sophisticated analyses can be defined with a few key strokes. As an added benefit, all analysis inputs and outputs can be readily exported into presentation-ready PowerPoint slides. ValueDriver is the perfect tool for those responsible for asset valuation and portfolio management activities.

Cennium Vaccine Financial Implications & Risk Model (Vaccine FIRM™) , Applied Strategies’ extremely flexible and data-rich forecasting tool, creates demand forecasts and donor and supplier ROI analyses for any type of vaccine for any market of interest. Analyses can be conducted by country, by region, or on a global basis given multiple competitive environments, vaccine pricing, and donor funding scenarios. Vaccine FIRM is the perfect tool for those considering emerging market strategies and significant global capacity scale-up.

For Life Sciences companies in need of tailored solutions, we leverage the industry knowledge and experience of our staff, existing components of our off-the-shelf applications, and the unique knowledge of our clients to rapidly and cost-effectively develop targeted decision-support tools that enable companies to make better decisions about the key business and operational challenges they face.